A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 12-Week Study to Assess the Efficacy and Safety of Etrasimod in Subjects with Moderately to Severely Active Ulcerative Colitis
- Sparrow, Miles (Primary Chief Investigator (PCI))
- McKenzie, Jo (Project Manager)
Project: Research